{"id":580173,"date":"2025-06-18T23:32:39","date_gmt":"2025-06-19T06:32:39","guid":{"rendered":"https:\/\/nai500.com\/blog\/2025\/06\/%e6%8e%98%e9%87%91%e5%9f%ba%e5%9b%a0%e5%89%aa%e5%88%80%ef%bc%9a%e8%81%9a%e7%84%a6%e4%ba%94%e5%8f%aacrispr%e5%9f%ba%e5%9b%a0%e7%bc%96%e8%be%91%e6%8a%80%e6%9c%afetf\/"},"modified":"2025-06-18T23:33:20","modified_gmt":"2025-06-19T06:33:20","slug":"%e5%9f%ba%e5%9b%a0%e5%89%aa%e5%88%80-%e4%ba%94%e9%9a%bbcrispr%e5%9f%ba%e5%9b%a0%e7%b7%a8%e8%bc%af%e6%8a%80%e8%a1%93etf","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2025\/06\/%e5%9f%ba%e5%9b%a0%e5%89%aa%e5%88%80-%e4%ba%94%e9%9a%bbcrispr%e5%9f%ba%e5%9b%a0%e7%b7%a8%e8%bc%af%e6%8a%80%e8%a1%93etf\/","title":{"rendered":"\u6398\u91d1\u201c\u57fa\u56e0\u526a\u5200”\uff1a\u805a\u7126\u4e94\u96bbCRISPR\u57fa\u56e0\u7de8\u8f2f\u6280\u8853ETF"},"content":{"rendered":"

\u76ee\u524d\uff0cCRISPR\u57fa\u56e0\u7de8\u8f2f\u6280\u8853\u6709\u6f5b\u529b\u901a\u904e\u4fee\u6539DNA\u4f86\u7cfe\u6b63\u7a81\u8b8a\uff0c\u5f9e\u800c\u6539\u8b8a\u591a\u7a2e\u75be\u75c5\u7684\u6cbb\u7642\u65b9\u5f0f\uff0c\u751a\u81f3\u53ef\u80fd\u6cbb\u7652\u75be\u75c5\u3002\u5982\u6b64\u985b\u8986\u6027\u7684\u751f\u547d\u79d1\u5b78\u6280\u8853\u9769\u547d\uff0c\u81ea\u7136\u6703\u5438\u5f15\u773e\u591a\u6295\u8cc7\u8005\u7684\u95dc\u6ce8\u3002\u5c0d\u65bc\u60f3\u8981\u7701\u5fc3\uff0c\u540c\u6642\u5206\u6563\u98a8\u96aa\u7684\u6295\u8cc7\u8005\u4f86\u8aaa\uff0c\u8ffd\u8e64CRISPR\u4ee5\u53ca\u66f4\u5ee3\u6cdb\u57fa\u56e0\u7de8\u8f2f\u6280\u8853\u7684\u4ea4\u6613\u6240\u4ea4\u6613\u57fa\u91d1\uff08ETF\uff09\u5c31\u662f\u4e0d\u4e8c\u4e4b\u9078\u3002<\/p>\n

\u53ef\u4f9b\u6295\u8cc7\u8005\u8cfc\u8cb7\u7684\u751f\u7269\u6280\u8853ETF\u4e0d\u5c11\uff0c\u4f46\u5c08\u6ce8\u4e8eCRISPR\u548c\u57fa\u56e0\u7de8\u8f2f\u6280\u8853\u7684ETF\u6578\u91cf\u76f8\u5c0d\u6709\u9650\u3002\u4ee5\u4e0b\u662f\u5c08\u6ce8CRISPR\u57fa\u56e0\u7de8\u8f2f\u7684\u524d\u4e94\u5927ETF\uff08\u6578\u64da\u622a\u81f32025\u5e746\u670813\u65e5\uff09\u3002<\/p>\n\n\n\n\n\n\n\n\n\n
ETF<\/strong>\u540d\u7a31<\/strong><\/td>\n\u8cbb\u7387<\/strong><\/td>\n<\/tr>\n<\/thead>\n
ARK Genomic Revolution ETF (NYSEMKT:ARKG)<\/a><\/td>\n0.75%<\/td>\n<\/tr>\n
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)<\/td>\n0.5%<\/td>\n<\/tr>\n
Invesco Dynamic Biotechnology & Genome ETF (NYSEMKT:PBE)<\/td>\n0.58%<\/td>\n<\/tr>\n
iShares Genomics Immunology and Healthcare ETF (NYSEMKT:IDNA)<\/td>\n0.47%<\/td>\n<\/tr>\n
WisdomTree BioRevolution Fund (BATS:WDNA)<\/td>\n0.45%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

1.\u00a0 ARK Genomic Revolution ETF (ARKG)<\/h2>\n

\u8a72ETF\u662f\u7531\u6728\u982d\u59d0\u7684ARK Invest\u8a2d\u7acb\u7684\u591a\u96bbETF\u4e4b\u4e00\u3002\u9019\u662f\u4e00\u96bb\u4e3b\u52d5\u7ba1\u7406\u578bETF\uff0c\u5c08\u6ce8\u4e8e\u90a3\u4e9b\u5c07\u57fa\u56e0\u7d44\u5b78\u878d\u5165\u696d\u52d9\u5f9e\u800c\u53d7\u76ca\u7684\u516c\u53f8\u3002\u8a72ETF\u7684\u7b2c\u4e8c\u5927\u6301\u5009\u662fCRISPR\u57fa\u56e0\u7de8\u8f2f\u9818\u57df\u7684\u5148\u9a45\u2014\u2014CRISPR Therapeutics (CRSP)\uff0c\u4ee5\u53ca\u76f8\u95dc\u7684\u88fd\u85e5\u516c\u53f8\u80a1\u7968\uff0c\u5305\u62ecBeam Therapeutics (BEAM)\u3001Intellia Therapeutics (NTLA)\u3001\u518d\u751f\u5143\u88fd\u85e5 (REGN)\uff08\u8207Intellia\u5408\u4f5c\uff09\u4ee5\u53ca\u798f\u6cf0\u88fd\u85e5 (VRTX)\u3002<\/p>\n

2023\u5e7412\u6708\uff0c\u798f\u6cf0\u88fd\u85e5\u8207CRISPR Therapeutics\u7372\u5f97\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6279\u51c6\uff0c\u5c07CRISPR\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5Casgevy\u7528\u65bc\u6cbb\u7642\u942e\u72c0\u7d30\u80de\u75c5\u30022024\u5e741\u6708\uff0c\u9019\u5169\u5bb6\u5408\u4f5c\u5925\u4f34\u53c8\u7372\u5f97FDA\u6279\u51c6\uff0c\u5c07\u8a72\u7642\u6cd5\u7528\u65bc\u6cbb\u7642\u8f38\u8840\u4f9d\u8cf4\u6027\u03b2\u5730\u4e2d\u6d77\u8ca7\u8840\u3002<\/p>\n

2.\u00a0 Global X Genomics & Biotechnology ETF (GNOM)<\/h2>\n

\u8a72ETF\u7531\u97d3\u570b\u6295\u8cc7\u516c\u53f8Mirae Asset Financial Group\u904b\u71df\uff0c\u65e8\u5728\u6295\u8cc7\u90a3\u4e9b\u5c07\u5f9e\u57fa\u56e0\u7d44\u5b78\u9032\u6b65\uff08\u5305\u62ec\u57fa\u56e0\u7de8\u8f2f\u548c\u57fa\u56e0\u7d44\u6e2c\u5e8f\u7684\u7a81\u7834\uff09\u4e2d\u53d7\u76ca\u7684\u516c\u53f8\u3002GNOM\u76ee\u524d\u6301\u670949\u53ea\u80a1\u7968\uff0c\u5176\u4e2d\u4e94\u5bb6\u2014\u2014CRISPR Therapeutics\u3001\u798f\u6cf0\u88fd\u85e5\u3001Intellia Therapeutics\u3001Beam Therapeutics\u548cVerve Therapeutics (VERV)\u2014\u2014\u6b63\u5728\u92b7\u552e\u6216\u958b\u767cCRISPR\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5\u3002\u53e6\u5916\u5169\u5bb6\u6301\u5009\u516c\u53f8Genscript\u548cAgilent (A) \u5411\u85e5\u7269\u958b\u767c\u5546\u548c\u7814\u7a76\u4eba\u54e1\u63d0\u4f9bCRISPR\u7522\u54c1\u548c\u670d\u52d9\u3002<\/p>\n

3.\u00a0 Invesco Dynamic Biotechnology & Genome ETF (PBE)<\/h2>\n

\u8a72ETF\u65e8\u5728\u8ffd\u8e64\u4e00\u500b\u5305\u542b30\u5bb6\u7f8e\u570b\u751f\u7269\u6280\u8853\u548c\u57fa\u56e0\u7d44\u516c\u53f8\u7684\u6307\u6578\u3002PBE\u7684\u524d\u5341\u5927\u6301\u5009\u4e2d\uff0c\u6709\u5169\u5bb6\u8207\u57fa\u56e0\u7de8\u8f2f\u76f8\u95dc\uff1a\u798f\u6cf0\u88fd\u85e5\u548c\u5409\u5229\u5fb7\u79d1\u5b78 (GILD)\u3002\u798f\u6cf0\u8207CRISPR Therapeutics\u5408\u4f5c\u92b7\u552eCRISPR\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5Casgevy\u3002\u5409\u5229\u5fb7\u5247\u8207Sangamo Therapeutics (SGMO) \u5408\u4f5c\uff0c\u5229\u7528Sangamo\u7684\u92c5\u6307\u6838\u9178\u9176\uff08ZFN\uff09\u57fa\u56e0\u7de8\u8f2f\u65b9\u6cd5\uff08\u4e00\u7a2e\u6bd4CRISPR\u66f4\u65e9\u7684\u6280\u8853\uff09\u958b\u767c\u764c\u75c7\u7d30\u80de\u7642\u6cd5\u3002<\/p>\n

4.\u00a0 iShares Genomics Immunology and Healthcare ETF (IDNA)<\/h2>\n

\u8a72ETF\u8ffd\u8e64\u4e00\u500b\u805a\u7126\u4e8e\u57fa\u56e0\u7d44\u5b78\u3001\u514d\u75ab\u5b78\u548c\u751f\u7269\u5de5\u7a0b\u9818\u57df\u7684\u767c\u9054\u53ca\u65b0\u8208\u5e02\u5834\u516c\u53f8\u6307\u6578\u3002\u76ee\u524d\u6301\u670951\u5bb6\u88fd\u85e5\u548c\u751f\u7269\u6280\u8853\u516c\u53f8\u7684\u80a1\u7968\u3002\u8a72ETF\u7684\u6301\u5009\u5305\u62ec\u524d\u8ff0\u4e94\u5bb6\u8207CRISPR\u57fa\u56e0\u7de8\u8f2f\u76f8\u95dc\u7684\u516c\u53f8\u80a1\u7968\uff1aCRISPR Therapeutics\u3001Verve Therapeutics\u3001Beam Therapeutics\u3001Intellia Therapeutics\u548c\u518d\u751f\u5143\u88fd\u85e5\u3002<\/p>\n

5.\u00a0 WisdomTree BioRevolution Fund (WDNA)<\/h2>\n

\u8a72ETF\u65e8\u5728\u8ffd\u8e64\u4e00\u500b\u7531\u201c\u5c07\u56e0\u907a\u50b3\u5b78\u548c\u751f\u7269\u6280\u8853\u9032\u6b65\u800c\u767c\u751f\u91cd\u5927\u8b8a\u9769\u201d\u7684\u516c\u53f8\u7d44\u6210\u7684\u6307\u6578\u3002\u8207\u5176\u4ed6ETF\u985e\u4f3c\uff0cWDNA\u4e26\u4e0d\u50c5\u9650\u65bcCRISPR\u6216\u57fa\u56e0\u7de8\u8f2f\u985e\u80a1\u7968\u3002\u9664\u4e86Beam Therapeutics\u3001CRISPR Therapeutics\u3001\u5409\u5229\u5fb7\u79d1\u5b78\u3001Intellia Therapeutics\u3001\u518d\u751f\u5143\u88fd\u85e5\u3001\u798f\u6cf0\u88fd\u85e5\u548cVerve Therapeutics\uff0c\u5b83\u9084\u6301\u6709\u963f\u65af\u5229\u5eb7 (AZN) \u548cCaribou Biosciences (CRBU) \u9019\u5169\u5bb6\u5728\u958b\u767cCRISPR\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5\u7684\u516c\u53f8\u80a1\u7968\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u76ee\u524d\uff0cCRISPR\u57fa\u56e0\u7de8\u8f2f\u6280\u8853\u6709\u6f5b\u529b\u901a\u904e\u4fee\u6539DNA\u4f86\u7cfe\u6b63\u7a81\u8b8a\uff0c\u5f9e\u800c\u6539\u8b8a\u591a\u7a2e\u75be\u75c5\u7684\u6cbb\u7642\u65b9\u5f0f\uff0c\u751a\u81f3\u53ef\u80fd\u6cbb\u7652\u75be\u75c5\u3002\u5982 […]<\/p>\n","protected":false},"author":27,"featured_media":569422,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[2191,809,927,564],"class_list":["post-580173","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-etf-tch","tag-809","tag-927","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/580173","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=580173"}],"version-history":[{"count":3,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/580173\/revisions"}],"predecessor-version":[{"id":580176,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/580173\/revisions\/580176"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/569422"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=580173"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=580173"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=580173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}